Large-scale testing (Phase 3)Study completedNCT02606461What this trial is testingSelinexor in Advanced LiposarcomaWho this might be right forDedifferentiated Liposarcoma Karyopharm Therapeutics Inc 342
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694871What this trial is testingTesting the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated LiposarcomaWho this might be right forAdvanced Dedifferentiated LiposarcomaLocally Advanced Dedifferentiated LiposarcomaMetastatic Dedifferentiated Liposarcoma+3 more Alliance for Clinical Trials in Oncology 77
Early research (Phase 1)Looking for participantsNCT05711615What this trial is testingTesting Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced SarcomaWho this might be right forMetastatic Dedifferentiated LiposarcomaMetastatic LeiomyosarcomaMetastatic Myxofibrosarcoma+9 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT02500797What this trial is testingNivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by SurgeryWho this might be right forLocally Advanced Bone SarcomaLocally Advanced Dedifferentiated LiposarcomaLocally Advanced Gastrointestinal Stromal Tumor+18 more National Cancer Institute (NCI) 164
Testing effectiveness (Phase 2)Active Not RecruitingNCT05886634What this trial is testingEtrumadenant and Zimberelimab in People With Dedifferentiated LiposarcomaWho this might be right forDedifferentiated LiposarcomaSoft Tissue SarcomaSarcoma,Soft Tissue+4 more Memorial Sloan Kettering Cancer Center 16
Testing effectiveness (Phase 2)Ended earlyNCT01876043What this trial is testingEfficacy and Safety of Plitidepsin in Patients With Advanced Unresectable or Metastatic, Relapsed/Refractory, Dedifferentiated Liposarcoma (DLPS): an Exploratory Phase II Multicenter TrialWho this might be right forAdult Patients With Unresectable Locally Advanced or Metastatic, Relapsed/Refractory Dedifferentiated Liposarcoma Institut Bergonié 24
Large-scale testing (Phase 3)Looking for participantsNCT06422806What this trial is testingMeasuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasWho this might be right forMetastatic Dedifferentiated LiposarcomaMetastatic Undifferentiated Pleomorphic SarcomaStage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8+3 more National Cancer Institute (NCI) 365
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06694324What this trial is testingFirst-line Treatment of Advanced/unresectable DDLPSWho this might be right forDedifferentiated LiposarcomaSoft Tissue Sarcoma (STS) Fudan University 49
Testing effectiveness (Phase 2)UnknownNCT03989596What this trial is testingHypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue SarcomasWho this might be right forSarcomaAlveolar Soft Part SarcomaClear Cell Sarcoma+8 more Maria Sklodowska-Curie National Research Institute of Oncology 30
Testing effectiveness (Phase 2)Study completedNCT02821507What this trial is testingSirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and ChondrosarcomaWho this might be right forConventional ChondrosarcomaMyxoid LiposarcomaMesenchymal Chondrosarcoma+1 more Leiden University Medical Center 70
Testing effectiveness (Phase 2)Looking for participantsNCT06843967What this trial is testingMirdametinib in Combination With Palbociclib in People With LiposarcomaWho this might be right forWell Differentiated LiposarcomaDedifferentiated LiposarcomaLiposarcoma+6 more Memorial Sloan Kettering Cancer Center 54